Weekly CEO Buy Highlights: Huntington Bancshares, Brown & Brown Inc, The Greenbrier Companies, Prospect Capital, and Handsen Medical

Author's Avatar
Apr 25, 2009
According to GuruFocus Insider Data, these are the largest CEO buys during the past week.


Huntington Bancshares Inc. (HBAN, Financial): President, CEO & Chairman Stephen D Steinour Bought 300,000 Shares


President, CEO & Chairman of Huntington Bancshares Inc. (HBAN) Stephen D Steinour bought 300,000 shares on 04/22/2009 at an average price of $3.24. Huntington Bancshares is a multi-state bank holding company. Huntington Bancshares Inc. has a market cap of $1.19 billion; its shares were traded at around $3.24 with and P/S ratio of 0.6. The dividend yield of Huntington Bancshares Inc. stocks is 1.3%.


Huntington recently reported its first quarter 2009 results. The company reported a net loss of $2.4 billion, or $6.79 per common share. This was caused mainly by a net negative impact of $6.73 per share, caused by a noncash $2.6 billion goodwill impairment charge ($7.09 per common share).


Charles Brandes owns 695,605 shares as of 12/31/2008, which accounts for 0.03% of the $20.68 billion portfolio of Brandes Investment. Arnold Schneider owns 5,809,099 shares as of 12/31/2008, a decrease of 53.08% of from the previous quarter. This position accounts for 3.19% of the $1.4 billion portfolio of Schneider Capital Management.


Buy: President, CEO & Chairman Stephen D Steinour bought 300,000 shares of HBAN stock on 04/22/2009 at the average price of $3.4; the price of the stock has decreased by 4.71% since.


Brown & Brown Inc. (BRO, Financial): Chairman and CEO, 10% Owner Hyatt J Brown Bought 54,000 Shares


Chairman and CEO, 10% Owner of Brown & Brown Inc. (BRO) Hyatt J Brown bought 54,000 shares on 04/23/2009 at an average price of $18.26. Brown & Brown Inc. and its subsidiaries offer a broad range of insurance and reinsurance products and services as well as risk management third party administration managed health care and Medicare set-aside services and programs. It has a market cap of $2.59 billion; its shares were traded at around $18.26 with a P/E ratio of 15.3 and P/S ratio of 2.8. The dividend yield of Brown & Brown Inc. stocks is 1.6%. Brown & Brown Inc. had an annual average earning growth of 25% over the past 10 years. GuruFocus rated Brown & Brown Inc. the business predictability rank of 4.5-star.


Arnold Schneider owns 1,524,923 shares as of 12/31/2008, an increase of 68.55% from the previous quarter. This position accounts for 2.28% of the $1.4 billion portfolio of Schneider Capital Management. Ruane Cunniff owns 4,781,518 shares as of 12/31/2008, a decrease of 35.6% of from the previous quarter. This position accounts for 1.43% of the $6.97 billion portfolio of Ruane & Cunniff & Goldfarb Inc. Chris Davis owns 113,764 shares as of 12/31/2008, a decrease of 85.66% of from the previous quarter. This position accounts for less than 0.01% of the $52.56 billion portfolio of Davis Selected Advisers.


Buy: Chairman and CEO, 10% Owner Hyatt J Brown bought 54,000 shares of BRO stock on 04/23/2009 at the average price of $18.3; the price of the stock has decreased by 0.22% since.


The Greenbrier Companies Inc. (GBX, Financial): President & CEO William A Furman Bought 63,990 Shares


President & CEO of The Greenbrier Companies Inc. (GBX) William A Furman bought 63,990 shares during the past week at an average price of $7.86. Greenbrier Companies Inc. is a leading supplier of transportation equipment and services to the railroad and related industries. The company has a market cap of $130.9 million; its shares were traded at around $7.86 with a P/E ratio of 21.3 and P/S ratio of 0.1. The Greenbrier Companies Inc. had an annual average earning growth of 3.4% over the past 10 years.


John Keeley owns 1,991,300 shares as of 12/31/2008, which accounts for 0.23% of the $6 billion portfolio of Keeley Fund Management. T Boone Pickens sold out his holdings in the quarter that ended on 12/31/2008.


Buy: President & CEO William A Furman bought 1,400 shares of GBX stock on 04/21/2009 at the average price of $7.22; the price of the stock has increased by 8.86% since.


Prospect Capital Corp. (PSEC, Financial): CEO John F Barry Bought 50,000 Shares


CEO of Prospect Capital Corp. (PSEC) John F Barry bought 50,000 shares on 04/22/2009 at an average price of $8.57. Prospect Capital Corporation is a closed-end investment company that lends to and invests in private and microcap public businesses. Prospect Capital's investment objective is to generate both current income and capital appreciation through debt and equity investments. Prospect Capital Corp. has a market cap of $268.1 million; its shares were traded at around $8.57 with a P/E ratio of 3.6 and P/S ratio of 3.3. The dividend yield of Prospect Capital Corp. stocks is 18.9%.


PSEC recently reported its fourth quarter results for 2008. During the second half of 2008, net assets decreased by $1,820 from $429,623 as of the first half of 2008 to $427,803 as of 2008's second half. This net decrease in assets resulted from a $20,522 increase from operations, offset by $23,848 in dividends declared to the company's stockholders.


Buy: CEO John F Barry bought 50,000 shares of PSEC stock on 04/22/2009 at the average price of $8.01; the price of the stock has increased by 6.99% since.


Buy: CEO, Director John F Barry bought 10,000 more shares of PSEC stock on 02/18/2009 at the average price of $8.5; the price of the stock has increased by 0.82% since.


Buy: CEO, Director John F Barry bought 5,000 more shares of PSEC stock on 02/17/2009 at the average price of $8.63; the price of the stock has decreased by 0.7% since.


Buy: CEO, Director John F Barry bought 15,000 more shares of PSEC stock on 02/17/2009 at the average price of $8.53; the price of the stock has increased by 0.47% since.


Buy: CEO, Director John F Barry bought 5,000 more shares of PSEC stock on 02/17/2009 at the average price of $8.64; the price of the stock has decreased by 0.81% since.


Recent Trades of Prospect Capital Corp. by CFO:


Buy: CFO & CCO Brian H Oswald bought 1,000 shares of PSEC stock on 02/17/2009 at the average price of $8.5; the price of the stock has increased by 0.82% since.


Buy: CFO & CCO Brian H Oswald bought 1,000 more shares of PSEC stock on 02/13/2009 at the average price of $8.9; the price of the stock has decreased by 3.71% since.


Recent Trades of Prospect Capital Corp. by Directors and Officers:


Buy: Director Graham Anderson bought 1,000 shares of PSEC stock on 02/24/2009 at the average price of $8.28; the price of the stock has increased by 3.5% since.


Buy: Director Eugene S Stark bought 500 shares of PSEC stock on 02/11/2009 at the average price of $9.75; the price of the stock has decreased by 12.1% since.


Handsen Medical, Inc. (HNSN, Financial): President and CEO Frederic H Moll Bought 92,308 Shares


President and CEO of HANSEN MEDICAL, INC. (HNSN) Frederic H Moll bought 92,308 shares on 04/17/2009 at an average price of $5.08. HANSEN MEDICAL INC. develops products & technology using robotics for the accurate positioning manipulation and control of catheters & catheter-based technologies. The company has a market cap of $128.5 million; its shares were traded at around $5.08 with and P/S ratio of 4.2.


Hansen recently reported its fourth quarter and full year 2008 results. The company announced that its total revenue for the three months ended December 31, 2008 was $7.3 million, a 74% increase compared to revenue of $4.2 million in the same period in 2007. "I am pleased with our progress and accomplishments during this past year," said Frederic Moll, M.D., co-founder and chief executive officer of Hansen Medical. "Adoption rates for our technology have been strong, with an installed base of 55 systems worldwide since we began commercial shipments in May 2007. In addition, we made important investments in our business and established partnerships that we believe put us in a position to significantly expand our technology in the years ahead. We are also encouraged by the progress we are making in markets outside EP and believe that this success provides evidence of the opportunity to leverage the Sensei platform into a variety of other interventional applications," concluded Dr. Moll.


Buy: President and CEO Frederic H Moll bought 92,308 shares of HNSN stock on 04/17/2009 at the average price of $3.25; the price of the stock has increased by 56.31% since.